Danesh Azar, Janghorbani Mohsen, Khalatbari Shila
Department of Obstetrics and Gynecology, Medical School, Isfahan University of Medical Sciences, Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.
J Res Med Sci. 2012 Oct;17(10):911-7.
To compare the effect of betamethasone and dexamethasone on maternal white blood cell (WBC) and differential count, erythrocyte sedimentation rate (ESR), Apgar score, maternal and fetal plasma glucose and length of admission to delivery, gestational age at delivery in women at risk of preterm labor (PTL).
Two hundred and forty pregnant women at risk for PTL with intact membranes or preterm premature rupture of the membranes (PPROM) were randomly allocated to receive either two intramuscular injections of 12 mg betamethasone at 24-h intervals or 4 injections of 6 mg dexamethasone at 12-h intervals. Blood tests for WBC and differential count, ESR and fasting plasma glucose were drawn before betamethasone or dexamethasone injection and after injection every 24 h for two days. Pregnancy outcome was assessed as Apgar score, fetal plasma glucose and length of gestation.
In the preterm delivery group with intact membranes, no significant differences were found between the two groups in the maternal serum indicators of infection. The mean gestational age at delivery, 1- and 5-min Apgar score were higher in the dexamethasone group than in the betamethasone group. In the PPROM group, a significant rise in WBC count was occurred (12.4 cells/mm(3) vs. 10.5 cells/mm(3), P < 0.001), none of the other maternal serum indicators of infection and outcome variables showed significant differences between the dexamethasone and betamethasone groups.
Dexamethasone compared to betamethasone significantly increased WBC count in women with PPROM, but in women at risk of PTL with intact membranes none of the maternal serum indicators of infection showed significant differences.
比较倍他米松和地塞米松对早产风险(PTL)女性的母体白细胞(WBC)及分类计数、红细胞沉降率(ESR)、阿氏评分、母体和胎儿血浆葡萄糖以及入院至分娩时间、分娩时孕周的影响。
240例有早产风险且胎膜完整或早产胎膜早破(PPROM)的孕妇被随机分配,接受每24小时间隔肌肉注射12毫克倍他米松2次,或每12小时间隔注射6毫克地塞米松4次。在注射倍他米松或地塞米松前以及注射后每24小时进行两天的血液检查,检测WBC及分类计数、ESR和空腹血浆葡萄糖。妊娠结局评估指标为阿氏评分、胎儿血浆葡萄糖和孕周。
在胎膜完整的早产组中,两组母体感染血清指标无显著差异。地塞米松组的平均分娩孕周、1分钟和5分钟阿氏评分高于倍他米松组。在PPROM组中,WBC计数显著升高(12.4细胞/mm³对10.5细胞/mm³,P<0.001),地塞米松组和倍他米松组之间其他母体感染血清指标和结局变量均无显著差异。
与倍他米松相比,地塞米松显著增加了PPROM女性的WBC计数,但在胎膜完整的PTL风险女性中,母体感染血清指标均无显著差异。